MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/diagnostics16060900

Медицинская библиотека · Diagnostics (Basel, Switzerland) · 2026

Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma.

Iizuka Takeshi, Kurita Yusuke, Honda Yu, Oda Takayuki, Yagi Shin, Hasegawa Sho, Sato Takamitsu, Hosono Kunihiro, Kobayashi Noritoshi, Endo Itaru, Kubota Kensuke, Yoneda Masato

СтатьяПеревод в очереди

Аннотация

Background/

Objectives

Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed for cholangiocarcinoma and often involves multiple procedures, potentially increasing the risk of post-ERCP pancreatitis (PEP). However, PEP characteristics in cholangiocarcinoma patients remain unclear. This study aimed to assess the incidence and diagnostic procedure-specific risk factors for PEP in patients with cholangiocarcinoma.

Methods

We retrospectively reviewed 218 ERCP procedures for cholangiocarcinoma performed at our hospital between January 2017 and March 2022. The incidence of PEP, severe PEP, and fatal PEP was recorded. Risk factors for PEP were analyzed using multivariate analysis, and severe cases were further evaluated.

Results

Among the 218 patients, 15 (6.9%) developed PEP, 4 (1.8%) had severe PEP, and 2 (0.9%) died. Multivariate analysis identified the pancreatic guidewire technique (PGW) (OR: 8.18; 95% CI: 2.52-26.53, p < 0.001) and intraductal ultrasonography (IDUS) (OR: 6.53; 95% CI: 2.01-21.25, p = 0.002) as significant risk factors. Both fatal cases involved naïve papilla and PGW and IDUS, with no pancreatic duct stent placement.

Conclusions

ERCP for cholangiocarcinoma carries a clinically relevant risk of severe or fatal PEP. In particular, ERCP-specific diagnostic procedures required for cholangiocarcinoma may confer a disease-specific risk profile distinct from that of general ERCP. PGW and IDUS were identified as major risk factors, especially in patients with a naïve papilla, in whom prophylactic pancreatic duct stenting should be considered to reduce the risk of severe or fatal outcomes.

Для цитирования: Iizuka Takeshi, Kurita Yusuke, Honda Yu, Oda Takayuki, Yagi Shin, Hasegawa Sho, Sato Takamitsu, Hosono Kunihiro, Kobayashi Noritoshi, Endo Itaru, Kubota Kensuke, Yoneda Masato. Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma.. Diagnostics (Basel, Switzerland). 2026. DOI: 10.3390/diagnostics16060900.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.